Biomedical Engineering Reference
In-Depth Information
R
2
R
2
R
2
R
2
Base and workup
Base and workup
[2,3]-Wittig rearrangement
HO
HO
O
R
3
O
R
3
R
3
R
3
[1,2]-Wittig rearrangement
R
1
R
1
R
1
R
1
SCHEME 8.27
Wittig rearrangements.
Wittig and Lohmann [148], and the [2,3]-rearrangement of an allyl alkyl ether to the
corresponding homoallylic alcohol, which was first reported by Wittig et al. [149a]
and then by Stevens and coworkers [149b] (Scheme 8.27).
The [1,2]-Wittig rearrangement takes place when R
1
(Scheme 8.27) is able to
stabilize a carbanion species. Unfortunately, the yields are usually moderate due to
the harsh conditions that are required to prevent the competing [1,4]-Wittig rear-
rangement. The [2,3]-Wittig rearrangement, on the other hand, proceeds under mild
reaction conditions and leads to higher chemical yields. It is worth pointing out that
the competing [1,2]-Wittig rearrangement can be avoided by carefully optimizing the
temperature. Typical conditions imply the use of LDA or
n
-BuLi as the base and
temperatures ranging from
85
C. The [2,3]-Wittig rearrangement is
highly stereoselective regarding the stereochemistry of the double bond and the two
newly formed stereogenic centers. The Still variant of the [2,3]-Wittig rearrange-
ment [150], which involves a tin-lithium exchange, was shown to be very useful, as
illustrated in the synthesis of (
60
Cto
þ
)-astrophylline [151].
An application of the [1,2]-Wittig rearrangement of hydroximates has recently
been reported by Naito and coworkers in their synthesis of (
þ
)-cytoxazone [152]
(Scheme 8.28).
The preparation of the 6,7-dihydroisobenzofuran ring moiety present in the
natural product (
)-xestoquinone was carried out using a very regiospecific [1,2]-
Wittig rearrangement of a carefully chosen precursor, itself prepared from
2-(
t
-butyldimethylsilyl)-3-(hydroxymethyl)furan (Scheme 8.29) [153].
One of the key strategic steps in the synthesis of (
þ
)-candelalide A, a natural
product isolated from
Sesquicillium candelabrum
that behaves as a novel blocker of
Ph
Ph
Ph
OH
OH
OH
O
O
O
LDA (4 equiv)
THF, -78°C
63%
N
N
N
R
S
+
O
OH
OH
MeO
MeO
MeO
NaBH
3
CN, 0°C
78%
Ph
OH
O
O
1. LiAlH
4
, rt
2. (Boc)
2
O, DMAP
1. O
3
, -78°C
2. NaBH
4
, -78 to 0°C
HN
O
HN
HN
O
O
50%
3. TFA
OH
36%
OH
MeO
MeO
MeO
(+)-Cytoxazone
SCHEME 8.28
[1,2]-Wittig rearrangement as a key step in the synthesis of (
þ
)-cytoxazone.
Search WWH ::
Custom Search